Abstracts

Citation

Carlum Shiu, Coleen K. Cunningham, M.D., Carrie Ziemniak, Petronella Muresan, M.S., Lawrence Fox, M.D., Ph.D., Aditya Gaur, M.D., Irma L. Febo Rodriguez, M.D., Katherine Luzuriaga, M.D., Deborah Persaud, M.D. Safety and analyses of very low-level viremia during therapeutic HIV-1 immunizations in young adults on HAART: long-term persistence of dominant plasma clones derived from residual replication-competent virus in CD4+ T cells. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D., Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Douglas J. Manion, M.D., F.R.C.P., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Safety and Antiviral Effect of Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Children.

Citation

Elizabeth (Betsy) J. McFarland, M.D., Daniel Johnson, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., James McNamara, M.D., Elizabeth Hawkins, Barbara E. Heckman, B.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Scharla Estep, M.S., R.Ph., Sanjay Gurunathan, M.D., Marc Gurwith, M.D., John S. Lambert, M.D. Safety and cell-mediated immune responses to a prime-boost immunization with ALVAC HIV vaccine and AIDSVAX B/B in newborns of HIV-infected mothers (PACTG 326). Presented at: 12th Conference on Retroviruses and Opportunistic Infections.

Citation

Safety and Efficacy of Dolutegravir (DTG; GSK1349572) in Treatment-Experienced HIV-1 Infected Adolescents: 24-Week Results from IMPAACT P1093.

Citation

Lameck Chinula, Sean S. Brummel, Lauren Ziemba, Lynda Stranix-Chibanda, Anne Coletti, Chelsea Krotje, Patrick Jean-Philippe, Lee Fairlie, Tichaona Vhembo, Deo Wabwire, Risa M. Hoffman, Paul E. Sax, Jeffrey S. Stringer, Judith S. Currier, Shahin Lockman. Safety and efficacy of DTG vs EFV and TDF vs TAF in pregnancy: IMPAACT 2010 trial. Presented at: CROI 2020; 2020 Mar 11.

Citation

Andrew A. Wiznia, M.D., Pearl Samson, M.S., Edward P. Acosta, Pharm.D., Hedy Teppler, M.D., Barney S. Graham, M.D., Ph.D., Terence Fenton, Ed.D., Edward Handelsman, M.D., Carol J. Worrell, M.D., Sharon Appelbaum Nachman, M.D. Safety and Efficacy of Raltegravir (RAL) in Pediatric HIV Infection. Preliminary analysis from IMPAACT P1066. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Edward Handelsman, M.D., Anna-Barbara Moscicki, M.D., Julie A. Patterson, B.S., Alfred J. Saah, M.D., M.P.H., David Radley, M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Myron Levin, M.D. Safety and immunogenicity of a quadrivalent vaccine to prevent human papilloma virus (HPV) infection in HIV-infected children: IMPAACT P1047. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Anna-Barbara Moscicki, M.D., Adriana Weinberg, M.D., Lin-Ye Song, Ph.D., Edward Handelsman, M.D., Julie A. Patterson, B.S., Alfred J. Saah, M.D., M.P.H., David Radley, M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Carlos A. Sattler, M.D., Myron Levin, M.D. Safety and immunogenicity of Gardasil in HIV-infected children. Presented at: 25th International Papillomavirus Conference.

Citation

Safety and Immunogenicity of HIN1 Influenza Immunization in HIV-1 Perinatally Infected Children and Youth. Presented at: 48th Annual Meeting of Infectious Diseases Society of Amercia.

Citation

Levin MJ, Lindsey JC, Kaplan SS, Schimana W, Lawrence J, Bwakura-Dangarembiziutsa M, Ogwu A, Chi B, Sato P, Siberry G, Nelson M, Hille D, Weinberg G, Weinberg A. Safety and Immunogenicity of Pentavalent Rotavirus Vaccine in HIV-Infected and HIV-Exposed Infants in Africa (IMPAACT P1072). Presented at: IDWeek 2015.